FENG'AN
News
On the afternoon of October 25, 2016, Zhejiang Feng'an Biopharmaceutical Co., Ltd. held the 2016 Fuketuo Hebei Province Distribution Conference at the Jingzhou International Hotel in Shijiazhuang City, Hebei Province. More than 200 people participated in the conference, and the conference was a complete success.
After the meeting began, Mr. Zheng from the Marketing Department of Zhejiang Feng'an Biopharmaceutical Co., Ltd. gave a speech on behalf of the company's leadership, expressing the company's confidence in the future of Fuketuo and elaborating from a strategic perspective that the company will comprehensively promote the academic guidance of Fuketuo's market. At the same time, the situation and trends in the field of immunotherapy at home and abroad were analyzed. Subsequently, Mr. Zhang from Hebei Maike made an important speech and briefly summarized the overall market situation in Hebei Province.
At the training meeting, Shi Biao, the Product Manager of the Marketing Department of Zhejiang Feng'an Biopharmaceutical Co., Ltd., gave a training presentation on Fuketuo, including the company's introduction, immune overview, Fuketuo product knowledge, clinical use observation and research of Fuketuo, as well as sales process explanation and case analysis. This enhanced the agent's confidence in Fuketuo and made it more clear that Fuketuo has a huge market space in clinical practice. During the meeting, a prize winning quiz session was set up, and the atmosphere on site was lively, achieving the expected training effect and receiving positive responses from the agents. After the training, two dealers in the Hebei Province region shared their experience in sales of Fuketuo, which provided valuable practical sales experience for the attending agents.
In the Q&A session, Mr. Zheng personally gave a detailed and in-depth explanation to the agents on how to carry out the business of Fu Ke Tong in obstetrics and gynecology, and gave a comprehensive introduction to Fu Ke Tong and the currently popular immunotherapy research worldwide. This brought the world's cutting-edge immunotherapy concepts to the attending agents and further conveyed the message that Fu Ke Tong has unlimited market prospects in China in the future! All the agents present were greatly encouraged and full of enthusiasm.
The meeting successfully concluded in the summary of Mr. Zhang from Hebei Maike.